11 04, 2023

Is Pfizer’s RSV Vaccine Advancements Enough to Earn the Stock a Buy?

By |2023-12-07T20:57:52+00:00April 11th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Pfizer (PFE) has climbed more than 2% in this shortened trading week, and this could be due to the recent advancements in their latest vaccine. The RSV (respiratory syncytial virus) vaccine has been found to be 82% effective in preventing a respiratory virus in infants. The way the vaccine works is through administration to [...]

Read More
3 03, 2023

Lantheus Holdings, Inc. Bolts 21% Higher on Year-Over-Year Triple Digit Revenue Growth

By |2023-12-07T20:59:40+00:00March 3rd, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Last week, the stock market had its worst week in 2023 down about 2-3% depending upon the index selected, but Lantheus Holdings, Inc. (Nasdaq:LNTH) stock price jumped 21.3%. That was because its worldwide revenues for the fourth quarter and full year 2022, accelerated 103.1% and 119.9%, respectively, over prior year periods. Although not a [...]

Read More
Go to Top